share_log

The Analyst Landscape: 4 Takes On 10x Genomics

Benzinga ·  Apr 18 13:00

In the last three months, 4 analysts have published ratings on 10x Genomics (NASDAQ:TXG), offering a diverse range of perspectives from bullish to bearish.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings22000
Last 30D10000
1M Ago01000
2M Ago00000
3M Ago11000

Analysts have set 12-month price targets for 10x Genomics, revealing an average target of $54.5, a high estimate of $63.00, and a low estimate of $45.00. This current average represents a 4.39% decrease from the previous average price target of $57.00.

price target chart

Investigating Analyst Ratings: An Elaborate Study

The analysis of recent analyst actions sheds light on the...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment